Discovery of Novel Promising Targets for Anti-AIDS Drug Developments by Computer Modeling: Application to the HIV-1 gp120 V3 Loop

被引:10
|
作者
Andrianov, Alexander M. [1 ]
Anishchenko, Ivan V.
Tuzikov, Alexander V. [2 ]
机构
[1] Natl Acad Sci Belarus, Inst Bioorgan Chem, Minsk 220141, BELARUS
[2] Natl Acad Sci Belarus, United Inst Informat Problems, Lab Math Cybernet, Minsk 220012, BELARUS
关键词
PRINCIPAL NEUTRALIZING DETERMINANT; N-LINKED GLYCOSYLATION; LOCAL STRUCTURAL-PROPERTIES; HIGHLY CONSERVED ARGININE; ENVELOPE GLYCOPROTEIN; CONFORMATIONAL PREFERENCES; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; CORECEPTOR USAGE; PROTEIN GP120;
D O I
10.1021/ci200255t
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The V3 loop on gp120 from HIV-1 is a focus of many research groups involved in anti-AIDS drug studies, because this region of the protein determines the preference of the virus for T-lymphocytes or primary macrophages. Although the V3 loop governs cell tropism and, for this reason, exhibits one of the most attractive targets for anti-HIV-1 drug developments, its high sequence variability is a major complicating factor. Nevertheless, the data on the spatial arrangement of V3 obtained here for different HIV-1 subtypes by computer modeling dearly show that, despite a wide range of 3D folds, this functionally important site of gp120 forms at least three structurally invariant segments, which contain residues critical for cell tropism. It is evident that these conserved V3 segments represent potential HIV-1 vulnerable spots and, therefore, provide a blueprint for the design of novel, potent and broad antiviral agents able to stop the HIV's spread.
引用
收藏
页码:2760 / 2767
页数:8
相关论文
共 45 条
  • [31] Association between gp120 envelope V1V2 and V4V5 variable loop profiles in a defined HIV-1 transmission cluster
    Pollakis, Georgios
    Baan, Elly
    van Werkhoven, Maaike B.
    Berkhout, Ben
    Bakker, Margreet
    Jurriaans, Suzanne
    Paxton, William A.
    AIDS, 2015, 29 (10) : 1161 - 1171
  • [32] The N-linked glycan g15 within the V3 loop of the HIV-1 external glycoprotein gp120 affects coreceptor usage, cellular tropism, and neutralization
    Polzer, S
    Dittmar, MT
    Schmitz, H
    Schreiber, M
    VIROLOGY, 2002, 304 (01) : 70 - 80
  • [33] Short Communication: HIV-1 Variants That Use Mouse CCR5 Reveal Critical Interactions of gp120's V3 Crown with CCR5 Extracellular Loop 1
    Platt, Emily J.
    Durnin, James P.
    Kabat, David
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2015, 31 (10) : 992 - 998
  • [34] A single amino acid substitution in the C4 region in gp120 confers enhanced neutralization of HIV-1 by modulating CD4 binding sites and V3 loop
    Ringe, Rajesh
    Sharma, Deepak
    Zolla-Pazner, Susan
    Phogat, Sanjay
    Risbud, Arun
    Thakar, Madhuri
    Paranjape, Ramesh
    Bhattacharya, Jayanta
    VIROLOGY, 2011, 418 (02) : 123 - 132
  • [35] Tyrosine sulfation in the second variable loop (V2) of HIV-1 gp120 stabilizes V2-V3 interaction and modulates neutralization sensitivity
    Cimbro, Raffaello
    Gallant, Thomas R.
    Dolan, Michael A.
    Guzzo, Christina
    Zhang, Peng
    Lin, Yin
    Miao, Huiyi
    Van Ryk, Donald
    Arthos, James
    Gorshkova, Inna
    Brown, Patrick H.
    Hurt, Darrell E.
    Lusso, Paolo
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (08) : 3152 - 3157
  • [36] Structural Comparison of Human Anti-HIV-1 gp120 V3 Monoclonal Antibodies of the Same Gene Usage Induced by Vaccination and Chronic Infection
    Chan, Kun-Wei
    Pan, Ruimin
    Costa, Matthew
    Gorny, Miroslaw K.
    Wang, Shixia
    Lu, Shan
    Kong, Xiang-Peng
    JOURNAL OF VIROLOGY, 2018, 92 (18)
  • [37] ANTIBODIES OF HIV-1 POSITIVE SUBJECTS AND EXPERIMENTALLY IMMUNIZED PRIMATES AND RODENTS BIND TO SEQUENCE DIVERGENT REGIONS OF THE 3RD VARIABLE DOMAIN (V3) OF GP120
    BOUDET, F
    GIRARD, M
    THEZE, J
    ZOUALI, M
    INTERNATIONAL IMMUNOLOGY, 1992, 4 (02) : 283 - 294
  • [38] A broad spectrum anti-HIV inhibitor significantly disturbs V1/V2 domain rearrangements of HIV-1 gp120 and inhibits virus entry
    Berinyuy, Emiliene
    Soliman, Mahmoud E. S.
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2016, 36 (02) : 119 - 129
  • [39] Viral surface glycoproteins, gp120 and gp41, as potential drug targets against HIV-1: Brief overview one quarter of a century past the approval of zidovudine, the first anti-retroviral drug
    Teixeira, Catia
    Gomes, Jose R. B.
    Gomes, Paula
    Maurel, Francois
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (04) : 979 - 992
  • [40] Substitution of gp120 C4 region compensates for V3 loss-of-fitness mutations in HIV-1 CRF01_AE co-receptor switching
    Yu, Yueyang
    Feng, Yi
    Zhou, Zehua
    Li, Kang
    Hu, Xiaoyan
    Liao, Lingjie
    Xing, Hui
    Shao, Yimig
    EMERGING MICROBES & INFECTIONS, 2023, 12 (01)